Not logged inA multivariate efficacy analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 study
Pavel, M. E.; Ferone, D.; Halperin, D.; Myrehaug, S.; Herrmann, K.; Kunz, P. L.; Chasen, B.; Castillon, J. Capdevila; Tafuto, S.; Oh, D-Y.; Yoo, C.; Falk, S.; Halfdanarson, T. R.; Folitar, I.; Zhang, Y.; de Herder, W. W.; Singh, S. .png)
Share.png)
SaveStandard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialMukherjee, Somnath; Qi, Cathy; Shaw, Rachel; Jones, Christopher M.; Bridgewater, John A.; Radhakrishna, Ganesh; Patel, Neel; Holmes, Jane; Virdee, Pradeep S.; Tranter, Bethan; Parsons, Philip; Falk, Stephen; Wasan, Harpreet S.; Ajithkumar, Thankamma, V; Holyoake, Daniel; Roy, Rajarshi; Scott-Brown, Martin; Hurt, Christopher N.; O'Neill, Eric; Sebag-Montefiore, David; Maughan, Tim S.; Hawkins, Maria A.; Corrie, Pippa Share Save Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical TrialGogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik Share Save Share Save First-line efficacy of [177Lu]Lu-DOTA-TATE in patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors by tumor grade and primary origin: Subgroup analysis of the phase III NETTER-2 studySingh, S.; Halperin, D.; Myrehaug, S.; Herrmann, K.; Pavel, M. E.; Kunz, P. L.; Chasen, B.; Capdevila, J.; Tafuto, S.; Oh, D-Y.; Yoo, C.; Falk, S.; Halfdanarson, T. R.; Folitar, I.; Zhang, Y.; de Herder, W. W.; Ferone, D. Share Save Share Save Genetic and immune landscape evolution in MMR-deficient colorectal cancerChalloner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Fong, Caroline; Barber, Louise J.; Anandappa, Gayathri; Crux, Richard; Assiotis, Ioannis; Fenwick, Kerry; Begum, Ruwaida; Begum, Dipa; Lund, Tom; Sivamanoharan, Nanna; Sansano, Harold B.; Domingo-Arada, Melissa; Tran, Amina; Pandha, Hardev; Church, David; Eccles, Bryony; Ellis, Richard; Falk, Stephen; Hill, Mark; Krell, Daniel; Murugaesu, Nirupa; Nolan, Luke; Potter, Vanessa; Saunders, Mark; Shiu, Kai-Keen; Guettler, Sebastian; Alexander, James L.; Lazare-Iglesias, Hector; Kinross, James; Murphy, Jamie; von Loga, Katharina; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trialReynolds, John, V; Preston, Shaun R.; O'Neill, Brian; Lowery, Maeve A.; Baeksgaard, Lene; Crosby, Thomas; Cunningham, Moya; Cuffe, Sinead; Griffiths, Gareth; Parker, Imelda; Risumlund, Signe Lenora; Roy, Rajarshi; Falk, Stephen; Hanna, George B.; Bartlett, Frederick R.; Alvarez-Iglesias, Alberto; Achiam, Michael P.; Nilsson, Magnus; Piessen, Guillaume; Ravi, Narayanasamy; O'Toole, Dermot; Johnston, Ciaran; Mcdermott, Raymond S.; Turkington, Richard C.; Wahed, Shajahan; Sothi, Sharmila; Ford, Hugo; Wadley, Martin S.; Power, Derek Share Save Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialMukherjee, Somnath; Hurt, Christopher N.; Adams, Richard; Bateman, Andrew; Bradley, Kevin M.; Bridges, Sarah; Falk, Stephen; Grif, Gareth; Gwynne, Sarah; Jones, Christopher M.; Markham, PhilipJ.; Maughan, Tim; Nixon, Lisette S.; Radhakrishna, Ganesh; Roy, Rajarshi; Schoenbuchner, Simon; Sheikh, Hamid; Spezi, Emiliano; Hawkins, Maria; Crosby, Thomas D. L. Share Save Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility studyJones, Christopher M.; O'Connor, Heather; O'Donovan, Maria; Hayward, Daniel; Blasko, Adrienn; Harman, Ruth; Malhotra, Shalini; Debiram-Beecham, Irene; Alias, Bincy; Bailey, Adam; Bateman, Andrew; Crosby, Tom D. L.; Falk, Stephen; Gollins, Simon; Hawkins, Maria A.; Kadri, Sudarshan; Levy, Stephanie; Radhakrishna, Ganesh; Roy, Rajarshi; Sripadam, Raj; Fitzgerald, Rebecca C.; Mukherjee, Somnath Share Save Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trialMukherjee, Somnath; Hurt, Christopher; Radhakrishna, Ganesh; Gwynne, Sarah; Bateman, Andrew; Gollins, Simon; Hawkins, Maria A.; Canham, Joanne; Grabsch, Heike I.; Falk, Stephen; Sharma, Ricky A.; Ray, Ruby; Roy, Rajarshi; Cox, Catrin; Maynard, Nick; Nixon, Lisette; Sebag-Montefiore, David J.; Maughan, Timothy; Griffiths, Gareth O.; Crosby, Tom D. L. Share Save Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinomaCorrie, P. G.; Qian, W.; Basu, B.; Valle, J. W.; Falk, S.; Iwuji, C.; Wasan, H.; Palmer, D.; Scott-Brown, M.; Wadsley, J.; Arif, S.; Bridgewater, J.; Propper, D.; Gillmore, R.; Gopinathan, A.; Skells, R.; Bundi, P.; Brais, R.; Dalchau, K.; Bax, L.; Chhabra, A.; Machin, A.; Dayim, A.; McAdam, K.; Cummins, S.; Wall, L.; Ellis, R.; Anthoney, A.; Evans, J.; Ma, Y. T.; Isherwood, C.; Neesse, A.; Tuveson, D.; Jodrell, D., I Share Save Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinomaThomas, Anne; Virdee, Pradeep S.; Eatock, Martin; Lord, Simon R.; Falk, Stephen; Anthoney, D. Alan; Turkington, Richard C.; Goff, Matthew; Elhussein, Leena; Collins, Linda; Love, Sharon; Moschandreas, Joanna; Middleton, Mark R. Share Save 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCTIvesono, Timothy; Boydo, Kathleen A.; Kerro, Rachel S.; Robles-Zuritao, Jose; Saunders, Mark P.; Briggso, Andrew H.; Cassidyo, Jim; Hollandero, Niels Henrik; Taberneroo, Josep; Haydon, Andrew; Glimeliuso, Bengt; Harkino, Andrea; Allano, Karen; McQueeno, John; Pearsono, Sarah; Waterstono, Ashita; Medleyo, Louise; Wilsono, Charles; Elliso, Richard; Essapen, Sharadah; Dhaddao, Amandeep S.; Harrison, Mark; Falko, Stephen; Raoufo, Sherif; Rees, Charlotte; Oleseno, Rene K.; Proppero, David; Bridgewatero, John; Azzabio, Ashraf; Farrugiao, David; Webbo, Andrew; Cunninghamo, David; Hickish, Tamas; Weavero, Andrew; Gollins, Simon; Wasano, Harpreet; Paulo, James Share Save Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialJoharatnam-Hogan, Nalinie; Cafferty, Fay; Hubner, Richard; Swinson, Daniel; Sothi, Sharmila; Gupta, Kamalnayan; Falk, Stephen; Patel, Kinnari; Warner, Nicola; Kunene, Victoria; Rowley, Sam; Khabra, Komel; Underwood, Tim; Jankowski, Janusz; Bridgewater, John; Crossley, Anne; Henson, Verity; Berkman, Lindy; Gilbert, Duncan; Kynaston, Howard; Ring, Alistair; Cameron, David; Din, Farhat; Graham, Janet; Iveson, Timothy; Adams, Richard; Thomas, Anne; Wilson, Richard; Pramesh, C. S.; Langley, Ruth Share Save Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy TrialJones, Robert P.; Psarelli, Eftychia-Eirini; Jackson, Richard; Ghaneh, Paula; Halloran, Christopher M.; Palmer, Daniel H.; Campbell, Fiona; Valle, Juan W.; Faluyi, Olusola; O'Reilly, Derek A.; Cunningham, David; Wadsley, Jonathan; Darby, Suzanne; Meyer, Tim; Gillmore, Roopinder; Anthoney, Alan; Lind, Pehr; Glimelius, Bengt; Falk, Stephen; Izbicki, Jakob R.; Middleton, Gary William; Cummins, Sebastian; Ross, Paul J.; Wasan, Harpreet; McDonald, Alec; Crosby, Tom; Ting, Yuk; Patel, Kinnari; Sherriff, David; Soomal, Rubin; Borg, David; Sothi, Sharmila; Hammel, Pascal; Lerch, Markus M.; Mayerle, Julia; Tjaden, Christine; Strobel, Oliver; Hackert, Thilo; Buchler, Markus W.; Neoptolemos, John P.; Hill, Mark; Corrie, Pippa; Hickish, Tamas; Napier, Mark; Slater, Sarah; Valle, Juan; Shablak, Alaaeldin; Cunnell, Michelle; Guimbaud, Rosine; Roques, Tom; Iveson, Tim; Jamil, Arshad; Robinson, Angus; Garcia-Alonso, Angel; Chang, David; Tsang, David; Wadd, Nick; Wall, Lucy; Nielsen, Niels Hilmer; Lerch, Markus; Mehta, Ajay; Sivaramalingam, Muthiah; Fyfe, David; Osborne, Richard; Blesing, Claire; Bulusu, Venkata Ramesh; Rathbone, Emma; Seitz, Jean-Francois; Beaumont, Erica; Dernedde, Ulrike; McAdam, Karen; Dimopoulos, Prokopios; Cominos, Mathilda; Askill, Colin; Piwowar, Andrzej; Bachet, Jean-Baptiste; Sumpter, Kate; Raouf, Sherif; Nicoll, Jonathan; Rees, Charlotte; Dhinakaran, Kathirvelu; Haux, Johan; Bengrine-Lefevre, Leila; Terrebonne, Eric; Shankland, Catherine; Palmer, Cheryl; Medley, Louise; Toy, Elizabeth; Kaur, Jasvinder; Gupta, Kamalnayan; Cheeseman, Sue; Patterson, Daniel; Candish, Charles; Thompson, Joyce; Coxon, Fareeda; Connolly, Caroline; McPhail, Neil; Williams, Rachel; Flygare, Petra; Elmlund, Mattias; Artru, Pascal; Millat, Bertrand Share Save The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapyLee, Siow Ming; Upadhyay, Sunil; Lewanski, Conrad; Falk, Stephen; Skailes, Geraldine; Woll, Penella J.; Hatton, Matthew; Lal, Rohit; Jones, Richard; Toy, Elizabeth; Rudd, Robin; Ngai, Yenting; Edwards, Alex; Hackshaw, Allan Share Save SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancerRobles-Zurita, Jose; Boyd, Kathleen A.; Briggs, Andrew H.; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Segelov, Eva; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S.; Hughes, Rob; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet S.; Paul, James Share Save A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUSGollins, Simon; West, Nicholas; Sebag-Montefiore, David; Susnerwala, Shabbir; Falk, Stephen; Brown, Nick; Saunders, Mark; Quirke, Philip; Ray, Ruby; Parsons, Philip; Griffiths, Gareth; Maughan, Tim; Adams, Richard; Hurt, Chris Share Save Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trialAdams, Richard; Brown, Ewan; Brown, Louise; Butler, Rachel; Falk, Stephen; Fisher, David; Kaplan, Richard; Quirke, Phil; Richman, Susan; Samuel, Leslie; Seligmann, Jenny; Seymour, Matt; Shiu, Kai Keen; Wasan, Harpreet; Wilson, Richard; Maughan, Tim Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
